Agent used in spinal surgery linked to higher complications rate, greater inpatient charges

A new study indicates that bone-morphogenetic protein (BMP; a biological agent used to promote bone creation) is used in 25 percent of spinal fusion procedures and is associated with a higher rate of complications than in fusions that did not use BMP, and greater hospital charges for all categories of spinal fusions, according to a report in the July 1 issue of JAMA.

Read the whole article on Physorg

More from Physorg